NDRG2 and NDRG4 expression is altered in glioblastoma and influences survival in patients with MGMT-methylated tumors

Aim: The N-myc down-regulated gene (NDRG) family is a group of genes that have predominantly tumor-suppressive effects. The goal of this study was to investigate the expression of NDRG2 and NDRG4 in surgical specimens of human glioblastoma and in normal brain tissue, and to search for correlations w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kolodziej, Malgorzata (VerfasserIn) , Weischer, Cornelia (VerfasserIn) , Reinges, Marcus H. T. (VerfasserIn) , Uhl, Eberhard (VerfasserIn) , Weigand, Markus A. (VerfasserIn) , Schwarm, Frank P. (VerfasserIn) , Schänzer, Anne (VerfasserIn) , Acker, Till (VerfasserIn) , Quint, Karl (VerfasserIn) , Uhle, Florian (VerfasserIn) , Stein, Marco (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: March 2016
In: Anticancer research
Year: 2016, Jahrgang: 36, Heft: 3, Pages: 887-897
ISSN:1791-7530
Online-Zugang:Verlag, Volltext: http://ar.iiarjournals.org/content/36/3/887
Verlag, Volltext: http://ar.iiarjournals.org/content/36/3/887.long
Volltext
Verfasserangaben:Malgorzata A. Kolodziej, Cornelia Weischer, Marcus H.T. Reinges, Eberhard Uhl, Marcus A. Weigand, Frank P. Schwarm, Anne Schänzer, Till Acker, Karl Quint, Florian Uhle and Marco Stein

MARC

LEADER 00000caa a2200000 c 4500
001 1690878096
003 DE-627
005 20220818000008.0
007 cr uuu---uuuuu
008 200224s2016 xx |||||o 00| ||eng c
035 |a (DE-627)1690878096 
035 |a (DE-599)KXP1690878096 
035 |a (OCoLC)1341307964 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kolodziej, Malgorzata  |d 1975-  |e VerfasserIn  |0 (DE-588)134086899  |0 (DE-627)560461658  |0 (DE-576)300303343  |4 aut 
245 1 0 |a NDRG2 and NDRG4 expression is altered in glioblastoma and influences survival in patients with MGMT-methylated tumors  |c Malgorzata A. Kolodziej, Cornelia Weischer, Marcus H.T. Reinges, Eberhard Uhl, Marcus A. Weigand, Frank P. Schwarm, Anne Schänzer, Till Acker, Karl Quint, Florian Uhle and Marco Stein 
264 1 |c March 2016 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Accepted February 11, 2016 
500 |a Gesehen am 24.02.2020 
520 |a Aim: The N-myc down-regulated gene (NDRG) family is a group of genes that have predominantly tumor-suppressive effects. The goal of this study was to investigate the expression of NDRG2 and NDRG4 in surgical specimens of human glioblastoma and in normal brain tissue, and to search for correlations with overall (OS) and progression-free survival (PFS). Materials and Methods: Samples from 44 patients (31 males, 13 females; mean age±SD=57.4±15.7 years) with primary (n=40) or recurrent glioblastoma (n=4) were analyzed by quantitative real-time polymerase chain reaction and immunohistochemistry, with dimensionless semiquantitative immunoreactivity score (IRS), ranging from 0-30] for expression of NDRG2 and NDRG4. Five non-tumorous autopsy brain specimens were used as controls. Results: On the protein level, expression of NDRG2 was significantly down-regulated in glioblastoma (IRS=3.5±3.0 vs. 8.8±3.3; p=0.001), while expression of NDRG4 was significantly up-regulated (IRS=5.4±3.7 vs. 0.75±0.4 vs, p<0.001). There was no statistically significant difference in PFS between a group of 15 patients with glioblastoma with MGMT methylation and enhanced expression of NDRG4 mRNA who were treated with adjuvant radiochemotherapy (temozolomide and 60 Gy) and a group of patients with low expression of NDRG4 mRNA [10 (range=5.5-14.2) months vs. 21 (range=10.7-31.3) months] (p=0.13). Conclusion: Expression of both NDRG2 and NDRG4 genes is significantly altered in glioblastomas. PFS among the patients with glioblastoma with MGMT methylation treated with radiochemotherapy differed significantly in high-expression groups compared to patients without MGMT methylation and without radiochemotherapy (p<0.05). 
650 4 |a Glioblastoma multiforme 
650 4 |a MGMT methylation 
650 4 |a NDRG2 
650 4 |a NDRG4 
650 4 |a patient survival 
700 1 |a Weischer, Cornelia  |e VerfasserIn  |4 aut 
700 1 |a Reinges, Marcus H. T.  |e VerfasserIn  |4 aut 
700 1 |a Uhl, Eberhard  |e VerfasserIn  |4 aut 
700 1 |a Weigand, Markus A.  |d 1967-  |e VerfasserIn  |0 (DE-588)1064970435  |0 (DE-627)815375239  |0 (DE-576)424658666  |4 aut 
700 1 |a Schwarm, Frank P.  |e VerfasserIn  |4 aut 
700 1 |a Schänzer, Anne  |e VerfasserIn  |4 aut 
700 1 |a Acker, Till  |e VerfasserIn  |4 aut 
700 1 |a Quint, Karl  |e VerfasserIn  |4 aut 
700 1 |a Uhle, Florian  |e VerfasserIn  |0 (DE-588)106860560X  |0 (DE-627)820511730  |0 (DE-576)427922534  |4 aut 
700 1 |a Stein, Marco  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Anticancer research  |d Kapandriti, Attiki, Greece : International Institute of Anticancer Research, 2004  |g 36(2016), 3, Seite 887-897  |h Online-Ressource  |w (DE-627)387478493  |w (DE-600)2145376-7  |w (DE-576)358408717  |x 1791-7530  |7 nnas  |a NDRG2 and NDRG4 expression is altered in glioblastoma and influences survival in patients with MGMT-methylated tumors 
773 1 8 |g volume:36  |g year:2016  |g number:3  |g pages:887-897  |g extent:11  |a NDRG2 and NDRG4 expression is altered in glioblastoma and influences survival in patients with MGMT-methylated tumors 
856 4 0 |u http://ar.iiarjournals.org/content/36/3/887  |x Verlag  |3 Volltext 
856 4 0 |u http://ar.iiarjournals.org/content/36/3/887.long  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20200224 
993 |a Article 
994 |a 2016 
998 |g 106860560X  |a Uhle, Florian  |m 106860560X:Uhle, Florian  |d 910000  |d 910300  |e 910000PU106860560X  |e 910300PU106860560X  |k 0/910000/  |k 1/910000/910300/  |p 10 
998 |g 1064970435  |a Weigand, Markus A.  |m 1064970435:Weigand, Markus A.  |d 910000  |d 910300  |e 910000PW1064970435  |e 910300PW1064970435  |k 0/910000/  |k 1/910000/910300/  |p 5 
999 |a KXP-PPN1690878096  |e 3597776507 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"language":["eng"],"name":{"displayForm":["International Institute of Anticancer Research"]},"id":{"issn":["1791-7530"],"zdb":["2145376-7"],"eki":["387478493"]},"pubHistory":["Nachgewiesen 24.2004 -"],"note":["Gesehen am 26.02.13"],"origin":[{"publisherPlace":"Kapandriti, Attiki, Greece","publisher":"International Institute of Anticancer Research","dateIssuedDisp":"2004-","dateIssuedKey":"2004"}],"recId":"387478493","type":{"media":"Online-Ressource","bibl":"periodical"},"physDesc":[{"extent":"Online-Ressource"}],"disp":"NDRG2 and NDRG4 expression is altered in glioblastoma and influences survival in patients with MGMT-methylated tumorsAnticancer research","part":{"pages":"887-897","year":"2016","text":"36(2016), 3, Seite 887-897","extent":"11","volume":"36","issue":"3"},"title":[{"title_sort":"Anticancer research","subtitle":"international journal of cancer research and treatment","title":"Anticancer research"}]}],"recId":"1690878096","origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"March 2016"}],"note":["Accepted February 11, 2016","Gesehen am 24.02.2020"],"physDesc":[{"extent":"11 S."}],"id":{"eki":["1690878096"]},"person":[{"family":"Kolodziej","display":"Kolodziej, Malgorzata","given":"Malgorzata","role":"aut"},{"family":"Weischer","display":"Weischer, Cornelia","given":"Cornelia","role":"aut"},{"family":"Reinges","role":"aut","display":"Reinges, Marcus H. T.","given":"Marcus H. T."},{"family":"Uhl","display":"Uhl, Eberhard","given":"Eberhard","role":"aut"},{"display":"Weigand, Markus A.","given":"Markus A.","role":"aut","family":"Weigand"},{"role":"aut","display":"Schwarm, Frank P.","given":"Frank P.","family":"Schwarm"},{"family":"Schänzer","role":"aut","given":"Anne","display":"Schänzer, Anne"},{"family":"Acker","role":"aut","given":"Till","display":"Acker, Till"},{"family":"Quint","role":"aut","given":"Karl","display":"Quint, Karl"},{"family":"Uhle","display":"Uhle, Florian","given":"Florian","role":"aut"},{"family":"Stein","role":"aut","given":"Marco","display":"Stein, Marco"}],"title":[{"title":"NDRG2 and NDRG4 expression is altered in glioblastoma and influences survival in patients with MGMT-methylated tumors","title_sort":"NDRG2 and NDRG4 expression is altered in glioblastoma and influences survival in patients with MGMT-methylated tumors"}],"name":{"displayForm":["Malgorzata A. Kolodziej, Cornelia Weischer, Marcus H.T. Reinges, Eberhard Uhl, Marcus A. Weigand, Frank P. Schwarm, Anne Schänzer, Till Acker, Karl Quint, Florian Uhle and Marco Stein"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a KOLODZIEJMNDRG2ANDND2016